Last updated on October 2012

Trial of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma

Brief description of study

The purpose of this study is to compare the efficacy and safety of cisplatin (CDDP) and epirubicin (EPI) in the treatment of transcatheter chemoembolization for Hepatocellular Carcinoma (HCC).

Clinical Study Identifier: NCT00843934

Find a site near you

Start Over